Last updated: November 16, 2023
Sponsor: University of Monastir
Overall Status: Active - Enrolling
Phase
N/A
Condition
Atherosclerosis
Treatment
Reactive hyperemia-peripheral arterial tonometry Index (RHI )
Clinical Study ID
NCT05331443
RHIFasting
Ages 18-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patient intending to fast Ramadan.
Exclusion
Exclusion Criteria:
- Age < 18 years old
- Hemodynamic instability.
- Myocardial infarction requiring urgent revascularization.
- Parkinsonism: tremor problem.
- Refusal, communication problem.
Study Design
Total Participants: 250
Treatment Group(s): 1
Primary Treatment: Reactive hyperemia-peripheral arterial tonometry Index (RHI )
Phase:
Study Start date:
March 15, 2022
Estimated Completion Date:
July 15, 2024
Study Description
Connect with a study center
University hospital Fattouma Bourguiba
Monastir, 5000
TunisiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.